Related Experiment Videos
Complete-type DiGeorge syndrome treated by bone marrow transplantation
T Matsumoto1, N Amamoto, T Kondoh
1Department of Pediatrics, Nagasaki University School of Medicine, Japan.
Bone Marrow Transplantation
|November 25, 1998
Summary
Bone marrow transplantation (BMT) offers effective treatment for DiGeorge syndrome, successfully restoring immune function in a patient with recurrent infections. This therapy, involving stem cell infusion from an HLA-identical sibling, normalized immune cell counts post-transplant.
Area of Science:
- Immunology
- Hematology
- Genetics
Background:
- DiGeorge syndrome is a genetic disorder characterized by immune deficiency due to thymus and parathyroid hypoplasia.
- Recurrent infections are a common and serious complication in infants with DiGeorge syndrome.
- Hematopoietic stem cell transplantation (HSCT) is a potential curative option for severe immunodeficiencies.
Observation:
- A patient diagnosed with DiGeorge syndrome experienced recurrent infections from birth.
- An initial bone marrow transplantation (BMT) using anti-thymocyte globulin without myeloablative conditioning did not result in detectable donor DNA.
- A second BMT with busulfan and cyclophosphamide conditioning achieved full donor chimerism and restoration of immune cell populations.
Findings:
- The second BMT successfully established full donor chimerism in the patient's bone marrow.
- Post-transplantation, CD3, CD4, and CD8 T-cell counts normalized within seven months.
- The patient's immune system recovered, indicated by the presence of normal levels of key immune cells.
Implications:
- Bone marrow transplantation is a viable and effective therapeutic strategy for managing DiGeorge syndrome.
- Conditioning regimens are crucial for successful engraftment in BMT for DiGeorge syndrome.
- Restoration of immune function through BMT can significantly improve outcomes for patients with DiGeorge syndrome.